Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MgSo4 Infusion for Oxygenation in Bariatric Surgery
NCT04769440Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Mar 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of magnesium sulfate in restrictive lung disease (RLD) (2 arms), sponsored by Ain Shams University. Primary endpoints: Partial Pressure of Oxygen and PaO2/FiO2 Ratio. Started Mar 2021; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
restrictive lung disease (RLD)
Beyond the preview
Go deeper on NCT04769440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04769440.